GILD logo

Gilead Sciences Inc (GILD)

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in patients. It also provides Epclusa, Livdelzi...

NASDAQHealthcareDrug Manufacturers - GeneralUSA

Company Profile

Stock Code
GILD
ISIN Code
US3755581036
Currency
US Dollar (USD)
IPO Date
1992-01-22

Contact Information

Company Address
333 Lakeside Drive, Foster City, CA, United States, 94404
Contact Phone
650 574 3000
Company Website
https://www.gilead.com
Fiscal Year End
December

Financial Highlights

Market Capitalization
$999,999.99
Gross Profit (TTM)
$999,999.99
Dividend Yield
2.44%
Return on Assets (TTM)
13.29%
EBITDA
$999,999.99
Revenue (TTM)
$999,999.99